Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock transcription factor 4 (HSF4) is a DNA-binding transcription factor that regulates the expression of heat shock response genes during cellular stress and plays a key role in eye lens development, especially in the terminal differentiation of lens fiber cells where it regulates denucleation and organelle degradation, partly by activating DNASE2B transcription. HSF4 variants are linked to inherited cataract disorders. It functions as both a transcriptional activator and repressor via different isoforms. Unlike other heat shock transcription factors, HSF4 lacks a specific carboxyl-terminal motif implicated in negative regulation, resulting in distinct regulatory properties[1][2][7]. No drugs are currently known to directly target HSF4 in a therapeutic context.
Not established for drugs; potential transcriptional modulation if a drug is found
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock transcription factor 4 (HSF4).